Simplicity Wealth LLC Purchases Shares of 38,054 CVS Health Corporation $CVS

Simplicity Wealth LLC acquired a new position in CVS Health Corporation (NYSE:CVS) during the second quarter, HoldingsChannel reports. The firm acquired 38,054 shares of the pharmacy operator’s stock, valued at approximately $3,937,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Handelsbanken Fonder AB raised its holdings in shares of CVS Health by 83.6% during the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock valued at $112,729,000 after buying an additional 496,124 shares during the period. State Street Corp boosted its holdings in CVS Health by 2.1% in the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares during the period. Legal & General Group Plc grew its position in CVS Health by 0.3% in the fourth quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock valued at $738,777,000 after acquiring an additional 31,249 shares in the last quarter. Deutsche Bank AG raised its stake in shares of CVS Health by 28.4% during the fourth quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock valued at $370,333,000 after purchasing an additional 1,031,998 shares during the period. Finally, Hussman Strategic Advisors Inc. acquired a new position in shares of CVS Health during the fourth quarter worth $3,333,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CVS Health

In other CVS Health news, Director Larry Robbins sold 1,983,538 shares of CVS Health stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total value of $187,345,164.10. Following the completion of the transaction, the director directly owned 6,213,261 shares in the company, valued at $586,842,501.45. The trade was a 24.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders have sold a total of 3,372,000 shares of company stock valued at $317,473,598 over the last quarter. Company insiders own 0.85% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of several analyst reports. Wells Fargo & Company upped their target price on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Robert W. Baird set a $107.00 target price on CVS Health in a research note on Thursday, August 6th. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Argus raised their price objective on CVS Health from $90.00 to $104.00 and gave the company a “buy” rating in a research note on Thursday, May 14th. Finally, Bank of America lifted their price objective on CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Twenty-two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $106.75.

CVS Health Trading Down 0.1%

Shares of NYSE CVS opened at $97.09 on Monday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The stock’s 50 day moving average price is $102.52 and its two-hundred day moving average price is $88.26. CVS Health Corporation has a 52-week low of $67.42 and a 52-week high of $110.68. The stock has a market capitalization of $124.18 billion, a P/E ratio of 25.69, a PEG ratio of 0.93 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same quarter last year, the firm earned $1.81 EPS. The business’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.